- United States
- /
- Chemicals
- /
- NYSE:ECL
Ecolab (ECL) Valuation Check After Strong Recent Share Price Momentum
Ecolab (ECL) is back on investor radars after recent share price strength, with the stock closing at $303.55 and posting double digit returns over the past month and past 3 months.
See our latest analysis for Ecolab.
That recent strength extends a solid run, with a 12.01% 1 month share price return and 15.58% year to date, while the 1 year total shareholder return of 17.04% sits against a very large 91.21% total shareholder return over three years. This suggests momentum has been building rather than fading.
If Ecolab’s move has you thinking more broadly about where capital could work hardest, it may be worth scanning our list of 22 top founder-led companies as potential next ideas.
With Ecolab now trading at $303.55, recent returns and current expectations are front and center. The key question is whether you are looking at an undervalued compounder or a stock already pricing in future growth.
Most Popular Narrative: 2.4% Overvalued
At $303.55 against a narrative fair value of $296.33, Ecolab is priced a little above that widely followed model, which hinges on specific growth and margin assumptions.
The analyst price target on Ecolab has been nudged higher by about $1 to roughly $296, as analysts incorporate slightly firmer assumptions around revenue growth, profit margins, and a modestly lower future P/E, supported by recent price target increases at several firms even as some ratings have turned more cautious.
Curious what kind of revenue growth, margin lift, and future earnings multiple are baked into that fair value, all discounted back at 7.58%? The full narrative lays out the earnings path, the profit profile, and the valuation bridge that need to hold together for this pricing to make sense.
Result: Fair Value of $296.33 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, softer demand in heavy industrial markets and rising costs linked to tariffs and local suppliers could pressure margins and challenge the earnings path behind that fair value.
Find out about the key risks to this Ecolab narrative.
Build Your Own Ecolab Narrative
If you see the story differently or prefer to test the numbers yourself, you can build a personalized Ecolab view in minutes by starting with Do it your way.
A great starting point for your Ecolab research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
Ready for your next investing move?
If you stop with just one idea, you could miss other opportunities that fit your style, so put the Simply Wall St Screener to work for you today.
- Target potential value opportunities by scanning our list of 51 high quality undervalued stocks that combine quality fundamentals with attractive pricing signals.
- Prioritize resilience by reviewing 85 resilient stocks with low risk scores if you want companies with lower overall risk scores to anchor your portfolio.
- Spot potential early-stage opportunities by checking 28 elite penny stocks with strong financials that pair smaller share prices with stronger financial characteristics.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Ecolab might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:ECL
Ecolab
Provides water, hygiene, and infection prevention solutions and services in the United States and internationally.
Proven track record average dividend payer.
Similar Companies
Market Insights
Weekly Picks

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Zoetis down -50% over the past year

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.
Recently Updated Narratives

The Underrated Transformation of a Digital Payments Giant

The C$4M Explorer Positioned to Become Europe's First Antimony Mine
Charter is undervalued - Here's why.
Popular Narratives
A wonderful business at reasonable price.


